跳至主要内容
临床试验/NCT01153360
NCT01153360已完成不适用

Peri-operative Oral Triiodothyronine Replacement Therapy to Decrease the Risk of Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery

Yonsei University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
compare the serum T3 concentrations and the number of patients with serum T3 concentrations below the normal range between the groups

研究概览

简要总结

This study is planned to medicate oral T3(Liothyronine)to the patients who are planned to have OPCAB(off- pump coronary bypass graft surgery. The aim of this study was to assess the effects of oral triiodothyronine (T3) therapy on postoperative thyroid hormone concentrations, hemodynamic variables and outcomes in patients undergoing OPCAB in a randomized, controlled trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are undergoing Off-pump coronary artery bypass graft

排除标准

  • No normal sinus rhythm,
  • History of thyroid disease
  • Abnormal thyroid hormone
  • Renal dysfunction
  • Hepatic dysfunction
  • LVEF <30%
  • Recent MI
  • Active infection 1~15

研究组 & 干预措施

T3

Experimental

triiodothyronine

干预措施: liothyronine sodium (Drug)

cyanocobalamin

Active Comparator

vitamin B12

干预措施: placebo (Drug)

结局指标

主要结局

compare the serum T3 concentrations and the number of patients with serum T3 concentrations below the normal range between the groups

时间窗: until 36 hours after surgery

次要结局

  • difference of hemodynamic performance and myocardial injury(during surgery and 36 hr after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yong-Sun Choi

assistant professor

Yonsei University

研究点 (1)

Loading locations...

相似试验